REG - Polar Cap Glb Health PCGH ZDP PLC - Transactions in a Closed Period

Polar Capital Global Healthcare TrustAnnouncement

15/11/2022 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221115:nRSO1868Ga&default-theme=true

RNS Number : 1868G  Polar Capital Global Health Tst PLC  15 November 2022

Polar Capital Global Healthcare Trust plc ("the Company")

 

Legal Entity Identifier: 549300YV7J2TWLE7PV84

 

 

15 November 2022

 

 

Transactions in a Closed Period

The Company confirms that:

 

·     all inside information (as defined in the Market Abuse Regulation)
which the Directors and the Company may have, in the period leading up to the
announcement of results in respect of the year ended 30 September 2022 has
previously been published or notified via a regulatory information service;
and

 

·      the Company's net asset value per share is calculated and
announced via a regulatory information service daily.

 

The Company is therefore not prohibited from dealing in its own securities
during the closed period, (as defined by the Market Abuse Regulation) which
will end on expected publication of the Company's annual results on or around
15 December 2022.

 

The Company further confirms that:

 

if, in the period leading up to the announcement of the annual results, the
Directors of the Company come into possession of any inside information, this
will be notified to a regulatory information service before any such dealings
are undertaken.

 

For further information, please contact:

 Tracey Lago, FCG

 Director                             +44 (0)20 7227 2700

 Polar Capital Secretarial Services

 Corporate Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUASORUUUAAAA